Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

LH Insider Trading

LABCORP HOLDINGS INC. | Services-Medical Laboratories

Comprehensive Trading Performance Summary

The investment history of corporate insiders at LABCORP HOLDINGS INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Medical Laboratories sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2010-10-08 23:15 2010-10-06 Walton Andrew Scott Officer - EVP OPT+S $79.50 5,000 $397,500 17,629 0.0%
2010-10-05 23:54 2010-10-01 Walton Andrew Scott Officer - EVP SELL $79.00 881 $69,599 17,629 -4.8%
2010-09-10 17:31 2010-09-08 MITTELSTAEDT ROBERT E JR Director OPT+S $74.32 1,896 $140,906 11,408 0.0%
2010-07-30 18:07 2010-07-26 Conrad Andrew J Officer - EVP, Chief Scientific Officer BUY $74.32 6,100 $453,347 6,100 +100.0%
2010-07-29 00:19 2010-07-26 Conrad Andrew J Officer - EVP, Chief Scientific Officer BUY $74.32 6,100 $453,347 33,651 +22.1%
2010-07-16 20:59 2010-07-14 Walton Andrew Scott Officer - EVP SELL $76.00 924 $70,224 18,510 -4.8%
2010-06-03 19:28 2010-06-01 LANE WENDY E Director OPT+S $75.77 617 $46,749 12,844 0.0%
2010-04-29 20:50 2010-04-27 BELINGARD JEAN-LUC Director OPT+S $78.20 4,116 $321,871 23,632 0.0%
2010-04-28 21:12 2010-04-26 LANE WENDY E Director OPT+S $79.74 648 $51,672 11,944 0.0%
2010-04-27 17:19 2010-04-23 LANE WENDY E Director OPT+S $79.92 4,655 $372,030 11,944 0.0%
2010-04-21 16:43 2010-04-19 Brecher Mark E Officer - Chief Medical Officer SELL $78.00 173 $13,494 2,808 -5.8%
2010-04-21 16:43 2010-04-19 Fonseca Lidia Officer - Chief Information Officer SELL $78.00 132 $10,296 3,475 -3.7%
2010-04-21 16:43 2010-04-19 KING DAVID P Director, Officer - President & CEO OPT+S $79.88 11,370 $908,230 84,682 0.0%
2010-04-14 19:33 2010-04-12 Hayes William B Officer - Chief Financial Officer, EVP OPT+S $76.09 6,684 $508,586 25,444 0.0%
2010-04-07 15:52 2010-04-05 MAC MAHON THOMAS P Director OPT+S $77.17 68,063 $5,252,224 83,897 0.0%
2010-04-05 19:45 2010-04-01 KING DAVID P Director, Officer - President & CEO SELL $77.00 3,500 $269,500 86,052 -3.9%
2010-04-02 18:50 2010-03-31 Fonseca Lidia Officer - Chief Information Officer SELL $76.00 163 $12,388 3,607 -4.3%
2010-03-29 21:11 2010-03-25 KING DAVID P Director, Officer - President & CEO OPT+S $74.10 33,872 $2,509,891 89,552 0.0%
2010-01-21 20:28 2010-01-19 MAC MAHON THOMAS P Director OPT+S $77.00 35,778 $2,755,035 63,897 0.0%
2010-01-15 22:48 2010-01-14 MAC MAHON THOMAS P Director OPT+S $77.00 14,559 $1,121,043 63,897 0.0%
2009-12-15 18:54 2009-12-11 Conrad Andrew J Officer - EVP, Chief Scientific Officer SELL $74.00 10,000 $740,000 24,200 -29.2%
2009-11-25 19:00 2009-11-24 MITTELSTAEDT ROBERT E JR Director OPT+S $74.60 4,116 $307,062 10,508 0.0%
2009-09-10 21:48 2009-09-08 LANE WENDY E Director OPT+S $68.70 4,116 $282,772 21,735 0.0%
2009-09-04 16:16 2009-09-02 LANE WENDY E Director SELL $68.78 2,604 $179,105 21,735 -10.7%
2009-08-19 22:10 2009-08-17 HARDISON DON M Officer - EVP, COO SELL $69.50 854 $59,353 23,776 -3.5%
2009-05-20 18:11 2009-05-18 HARDISON DON M Officer - EVP, COO SELL $61.73 1,407 $86,854 24,630 -5.4%
2009-05-04 19:48 2009-04-30 Walton Andrew Scott Officer - EVP SELL $63.88 3,500 $223,580 17,196 -16.9%
2009-02-24 23:22 2009-02-20 SMITH BRADFORD T Director SELL $61.67 6,066 $374,110 16,030 -27.5%
2008-11-06 01:23 2008-11-03 MAC MAHON THOMAS P Director OPT+S $61.70 276,237 $17,042,746 68,984 0.0%
2008-11-04 01:44 2008-10-30 LANE WENDY E Director BUY $60.96 400 $24,384 400 +100.0%
2008-08-06 00:33 2008-08-01 MAC MAHON THOMAS P Director SELL $66.99 54,139 $3,626,793 106,821 -33.6%
2008-08-06 00:27 2008-08-01 MAC MAHON THOMAS P Director SELL $67.17 79,400 $5,333,362 160,960 -33.0%
2008-08-06 00:21 2008-08-01 MAC MAHON THOMAS P Director SELL $67.51 43,497 $2,936,578 240,360 -15.3%
2008-08-05 23:51 2008-08-01 MAC MAHON THOMAS P Director OPT+S $67.80 60,800 $4,121,991 283,857 0.0%
2008-05-31 00:13 2008-05-28 KING DAVID P Director, Officer - President & CEO SELL $74.40 136 $10,118 67,636 -0.2%
2008-05-31 00:08 2008-05-28 KING DAVID P Director, Officer - President & CEO SELL $74.66 6,400 $477,801 67,772 -8.6%
2008-05-31 00:03 2008-05-28 KING DAVID P Director, Officer - President & CEO SELL $75.07 5,700 $427,913 74,172 -7.1%
2008-03-28 18:02 2008-03-26 Hayes William B Officer - Chief Financial Officer, EVP SELL $73.16 22,656 $1,657,416 18,804 -54.6%
2008-03-28 19:22 2008-03-26 SMITH BRADFORD T Director, Officer - EVP, Chf Legal Offcr,Secretary SELL $72.89 10,100 $736,175 26,137 -27.9%
2008-03-28 18:44 2008-03-26 SMITH BRADFORD T Director, Officer - EVP, Chf Legal Offcr,Secretary SELL $73.22 12,900 $944,480 36,237 -26.3%
2008-03-28 18:02 2008-03-26 SMITH BRADFORD T Director, Officer - EVP, Chf Legal Offcr,Secretary SELL $73.55 9,479 $697,191 49,137 -16.2%
2008-03-28 19:22 2008-03-26 LAI GOLDMAN MYLA Officer - EVP & Chief Medical Officer SELL $72.82 3,400 $247,589 22,660 -13.0%
2008-03-28 18:44 2008-03-26 LAI GOLDMAN MYLA Officer - EVP & Chief Medical Officer SELL $73.10 11,373 $831,407 26,060 -30.4%
2008-03-28 18:02 2008-03-26 LAI GOLDMAN MYLA Officer - EVP & Chief Medical Officer SELL $73.48 9,700 $712,772 37,433 -20.6%
2008-03-28 19:22 2008-03-26 MAC MAHON THOMAS P Director SELL $72.87 9,500 $692,263 143,713 -6.2%
2008-03-28 18:44 2008-03-26 MAC MAHON THOMAS P Director SELL $73.18 16,021 $1,172,366 153,213 -9.5%
2008-03-28 18:02 2008-03-26 MAC MAHON THOMAS P Director SELL $73.54 12,315 $905,643 169,234 -6.8%
2008-03-12 00:43 2008-03-07 Walton Andrew Scott Officer - EVP & CIO SELL $78.22 1,846 $144,394 10,341 -15.1%
2008-03-11 00:05 2008-03-06 Miller Benjamin R Officer - EVP, Sales & Marketing SELL $78.94 5,117 $403,942 10,135 -33.6%
2008-03-07 01:47 2008-03-03 SMITH BRADFORD T Director, Officer - EVP, Chf Legal Offcr,Secretary SELL $77.26 150 $11,589 26,137 -0.6%
SHOW ENTRIES

How to Interpret $LH Trades

Not every insider transaction in LABCORP HOLDINGS INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $LH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for LH

Insider activity data for LABCORP HOLDINGS INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $LH, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.